Forvis Mazars Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Sell
16,882
-160
-0.9% -$14.3K 0.03% 180
2025
Q4
$1.35M Sell
17,042
-861
-5% -$67.5K 0.03% 183
2025
Q3
$1.43M Sell
17,903
-555
-3% -$47.3K 0.03% 179
2025
Q2
$1.68M Sell
18,458
-78
-0.4% -$7.12K 0.04% 170
2025
Q1
$1.74M Sell
18,536
-258
-1% -$23.1K 0.04% 165
2024
Q4
$1.71M Buy
18,794
+108
+0.6% +$10.3K 0.04% 171
2024
Q3
$1.94M Buy
18,686
+255
+1% +$26K 0.04% 168
2024
Q2
$1.79M Sell
18,431
-135
-0.7% -$12.5K 0.04% 170
2024
Q1
$1.67M Sell
18,566
-1,163
-6% -$98.5K 0.04% 175
2023
Q4
$1.57M Sell
19,729
-1,517
-7% -$114K 0.04% 173
2023
Q3
$1.51M Sell
21,246
-197
-0.9% -$14.7K 0.05% 175
2023
Q2
$1.65M Buy
21,443
+3,319
+18% +$257K 0.05% 177
2023
Q1
$1.36M Buy
18,124
+1
+0% +$74 0.04% 179
2022
Q4
$1.43M Sell
18,123
-835
-4% -$62.6K 0.05% 174
2022
Q3
$1.33M Sell
18,958
-438
-2% -$34.3K 0.05% 173
2022
Q2
$1.55M Sell
19,396
-537
-3% -$42K 0.06% 149
2022
Q1
$1.51M Sell
19,933
-195
-1% -$15.4K 0.06% 128
2021
Q4
$1.72M Sell
20,128
-1,531
-7% -$120K 0.07% 114
2021
Q3
$1.64M Sell
21,659
-466
-2% -$37K 0.08% 109
2021
Q2
$1.8M Sell
22,125
-1,987
-8% -$162K 0.08% 100
2021
Q1
$1.9M Sell
24,112
-4,916
-17% -$385K 0.09% 97
2020
Q4
$2.48M Buy
29,028
+485
+2% +$40.1K 0.12% 87
2020
Q3
$2.2M Sell
28,543
-440
-2% -$33.5K 0.13% 84
2020
Q2
$2.12M Sell
28,983
-7,304
-20% -$519K 0.14% 80
2020
Q1
$2.41M Sell
36,287
-1,708
-4% -$120K 0.2% 54
2019
Q4
$2.62M Sell
37,995
-1,234
-3% -$84.1K 0.19% 68
2019
Q3
$2.88M Sell
39,229
-502
-1% -$36.4K 0.23% 59
2019
Q2
$2.85M Sell
39,731
-937
-2% -$66.5K 0.23% 60
2019
Q1
$2.79M Buy
40,668
+6,699
+20% +$433K 0.23% 63
2018
Q4
$2.02M Sell
33,969
-5,723
-14% -$358K 0.21% 59
2018
Q3
$2.66M Sell
39,692
-350
-0.9% -$23.3K 0.23% 55
2018
Q2
$2.6M Sell
40,042
-9,358
-19% -$612K 0.25% 58
2018
Q1
$3.54M Buy
49,400
+3,275
+7% +$236K 0.35% 40
2017
Q4
$3.48M Buy
46,125
+2,551
+6% +$186K 0.35% 39
2017
Q3
$3.17M Buy
43,574
+1,700
+4% +$123K 0.35% 36
2017
Q2
$3.1M Buy
41,874
+633
+2% +$47K 0.35% 40
2017
Q1
$3.02M Buy
41,241
+919
+2% +$64.3K 0.37% 36
2016
Q4
$2.64M Buy
40,322
+2,097
+5% +$144K 0.35% 43
2016
Q3
$2.83M Buy
38,225
+791
+2% +$58.5K 0.39% 38
2016
Q2
$2.74M Sell
37,434
-557
-1% -$39.7K 0.41% 37
2016
Q1
$2.68M Buy
37,991
+6
+0% +$399 0.43% 34
2015
Q4
$2.53M Buy
37,985
+425
+1% +$28.3K 0.38% 33
2015
Q3
$2.38M Sell
37,560
-3,377
-8% -$221K 0.42% 31
2015
Q2
$2.68M Sell
40,937
-1,304
-3% -$88.5K 0.4% 37
2015
Q1
$2.93M Buy
42,241
+81
+0.2% +$5.6K 0.42% 34
2014
Q4
$2.92M Buy
42,160
+775
+2% +$52.3K 0.48% 32
2014
Q3
$2.7M Buy
41,385
+286
+0.7% +$18.9K 0.47% 33
2014
Q2
$2.8M Sell
41,099
-775
-2% -$51.9K 0.48% 33
2014
Q1
$2.71M Buy
41,874
+2,728
+7% +$172K 0.48% 36
2013
Q4
$2.55M Sell
39,146
-7,964
-17% -$510K 0.47% 39
2013
Q3
$2.79M Sell
47,110
-23
-0% -$1.36K 0.57% 28
2013
Q2
$2.7M Buy
+47,133
New +$2.8M 2.14% 9

Other funds holding CL

Forvis Mazars Wealth Advisors's CL Position: Q1 2026 in Review

Forvis Mazars Wealth Advisors reduced its Colgate-Palmolive (CL) stake by 0.94% in Q1 2026, selling an estimated $14.3K and leaving 16,882 shares worth $1.44M. The position accounts for 0.03% of the portfolio, ranked #180.

Forvis Mazars Wealth Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.54M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Forvis Mazars Wealth Advisors held 16,882 shares of Colgate-Palmolive worth $1.44M as of Q1 2026.
  • Forvis Mazars Wealth Advisors sold 160 Colgate-Palmolive shares in Q1 2026, an estimated $14.3K.
  • Colgate-Palmolive made up 0.03% of Forvis Mazars Wealth Advisors's portfolio in Q1 2026, its #180 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Forvis Mazars Wealth Advisors's Colgate-Palmolive position peaked at $3.54M in Q1 2018.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.